Since COMT, AKT1, and ErbB-signaling are each implicated in both cancer and schizophrenia, NRG1-ErbB signaling in B lymphoblasts provides a biologically plausible research tool for elucidating cellular mechanisms relevant to both cancer biology and neurobiology. This evidence concerns the gene EGFR and schizophrenia.